Top Markets
#1 ADO Protocol ADO Protocol +194.72%
#2 Islamic Coin Islamic Coin +155.37%
#3 GoPlus Security GoPlus Security +40.11%
#4 GAIB AID GAIB AID +24.67%
#5 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +19.15%
#6 TENDIES TENDIES +16.67%
#7 Wrapped NXM Wrapped NXM +14.87%
#8 Verus Coin Verus Coin +13.64%
#9 Tutorial Tutorial +13.32%
#10 Pons Pons +12.61%
Coin of the day
ADO Protocol ADO Protocol
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
NeuroMetrix, Inc. NeuroMetrix, Inc.

NeuroMetrix, Inc.

NURO
Classifica tra le azioni #33738
NeuroMetrix, Inc. is a healthcare company focused on creating, manufacturing,... NeuroMetrix, Inc. is a healthcare company focused on creating, manufacturing, and distributing medical devices that stimulate and evaluate nerve function for both diagnostic and therapeutic applications. These products are available across a wide geographical area, including the United States, Europe, Japan, China, the Middle East, and Mexico. The company's core offerings include DPNCheck, a nerve conduction test used to identify and assess peripheral neuropathies such as diabetic peripheral neuropathy; Quell, a wearable device engineered for the relief and management of persistent pain; and the ADVANCE system, a dedicated platform for performing comprehensive nerve conduction studies. NeuroMetrix supplies its advanced solutions to a diverse clientele, encompassing managed care organizations, primary care providers, specialists like endocrinologists, podiatrists, various surgeons (including orthopedic and hand surgeons), occupational health practitioners, and neurology, pain medicine, and physical medicine and rehabilitation experts. Incorporated in 1996, the company's headquarters are located in Woburn, Massachusetts.
Prezzo delle azioni
$4.58
Ultima sincronizzazione: 2025-05-09
Capitalizzazione di mercato
$6.98M
Variazione (1 giorno)
0.00%
Variazione (1 anno)
0.00%
Paese
US
Scambia NeuroMetrix, Inc. (NURO)

Categoria

Healthcare
Utile per NeuroMetrix, Inc. (NURO)
Utile nel Dec 2024 TTM: $-7.81M
Secondo gli ultimi rapporti finanziari di NeuroMetrix, Inc., gli utili attuali della società sono $-7.81M. Nel 2023, la società ha registrato un utile di $-6.53M, una diminuzione rispetto a agli utili del 2022, che erano di $-4.42M. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Storico degli utili di NeuroMetrix, Inc. dal 2001 al 2026
Utile alla fine di ogni anno
Anno Utile Cambia
2026 (TTM) $-7.81M 0.00%
2024 $-7.81M 19.55%
2023 $-6.53M 47.84%
2022 $-4.42M 93.58%
2021 $-2.28M 9.05%
2020 $-2.09M -44.55%
2019 $-3.77M -16,083.96%
2018 $23.61K -100.18%
2017 $-12.86M -13.77%
2016 $-14.91M 62.32%
2015 $-9.19M 18.30%
2014 $-7.77M -3.15%
2013 $-8.02M -19.87%
2012 $-10.01M 0.26%
2011 $-9.98M -41.33%
2010 $-17.01M -99.86%
2009 $-11.92B 56,302.52%
2008 $-21.13M 152.19%
2007 $-8.38M -287.82%
2006 $4.46M 358.34%
2005 $973.26K -100.01%
2004 $-13.51B 0.00%
2003 0.00 0.00%
2002 0.00 0.00%
2001 0.00 0.00%
Utile per aziende simili o concorrenti
Azienda Utile Differenza negli utili Il paese
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
$7.51B -96,320.18%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
$5.15B -66,048.81%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
$5.56B -71,365.19%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
$3.86B -49,561.60%
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
$1.42B -18,260.26%
US